Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-03 Purchase | 2023-11-06 08:00 am | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 50,000 | $78.81 | $3,940,500 | 3,069,842 (Indirect Direct) | View |
| 2023-11-03 Purchase | 2023-11-06 08:00 am | Sarepta Therapeutics Inc. | SRPT | INGRAM DOUGLAS S President & CEO | 25,225 | $79.36 | $2,001,800 | 390,307 (Direct) | View |
| 2023-08-14 Purchase | 2023-08-15 08:00 am | Sarepta Therapeutics Inc. | SRPT | Chambers Michael Andrew Director | 9,979 | $109.47 | $1,092,429 | 253,427 (Indirect Direct) | View |
| 2023-08-11 Purchase | 2023-08-14 08:00 am | Sarepta Therapeutics Inc. | SRPT | Chambers Michael Andrew Director | 23,686 | $108.05 | $2,559,272 | 243,448 (Indirect Direct) | View |
| 2023-08-10 Purchase | 2023-08-11 07:40 am | Sarepta Therapeutics Inc. | SRPT | Chambers Michael Andrew Director | 34,867 | $106.15 | $3,701,067 | 219,762 (Indirect Direct) | View |
| 2023-08-04 Sale | 2023-08-08 8:00 pm | Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director | 15,000 | $106.72 | $1,600,800 | 20,994 (Direct) | View |
| 2022-11-17 Sale | 2022-11-21 8:00 pm | Sarepta Therapeutics Inc. | SRPT | Mayo Stephen Director | 858 | $109.92 | $94,311 | 6,387 (Direct) | View |
| 2022-09-14 Purchase | 2022-09-15 08:00 am | Sarepta Therapeutics Inc. | SRPT | Chambers Michael Andrew Director | 57,100 | $104.43 | $5,963,124 | 183,372 (Indirect Direct) | View |
| 2022-08-19 Purchase | 2022-08-22 08:30 am | Sarepta Therapeutics Inc. | SRPT | Chambers Michael Andrew Director | 46,170 | $108.28 | $4,999,230 | 126,272 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-11-17 Tax Withholding | 2023-11-20 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 4,508 | $82.98 | 65,751 (Direct) | View |
| 2023-11-03 Exercise | 2023-11-06 08:00 am | N/A N/A | Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director | 15,000 | $29.03 | 184,993 (Direct) | View |
| 2023-11-03 Exercise | 2023-11-06 08:00 am | 2015-02-28 2024-02-28 | Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director | 15,000 | $0 | 184,993 (Direct) | View |
| 2023-08-04 Exercise | 2023-08-08 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director | 15,000 | $29.03 | 20,994 (Direct) | View |
| 2023-08-04 Exercise | 2023-08-08 8:00 pm | 2015-02-28 2024-02-28 | Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director | 15,000 | $0 | 20,994 (Direct) | View |
| 2023-06-01 Tax Withholding | 2023-06-05 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward EVP, General Counsel | 89 | $123.6 | 28,096 (Direct) | View |
| 2023-03-30 Tax Withholding | 2023-04-04 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer | 307 | $136.66 | 26,367 (Direct) | View |
| 2023-03-08 Tax Withholding | 2023-03-10 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 912 | $153.19 | 70,170 (Direct) | View |
| 2023-03-08 Tax Withholding | 2023-03-10 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 744 | $153.19 | 34,679 (Direct) | View |
| 2023-03-08 Tax Withholding | 2023-03-10 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward SVP, General Counsel | 635 | $153.19 | 28,185 (Direct) | View |
| 2023-03-08 Tax Withholding | 2023-03-10 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer | 314 | $153.19 | 26,674 (Direct) | View |
| 2023-03-06 Option Award | 2023-03-08 8:01 pm | 2024-03-06 2033-03-06 | Sarepta Therapeutics Inc. | SRPT | Wigzell Hans Lennart Rudolf Director | 4,780 | $0 | 24,251 (Direct) | View |
| 2023-03-06 Tax Withholding | 2023-03-08 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer | 340 | $157.21 | 53,988 (Direct) | View |
| 2023-03-06 Option Award | 2023-03-08 8:00 pm | 2024-03-06 2033-03-06 | Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer | 31,500 | $0 | 53,988 (Direct) | View |
| 2023-03-06 Tax Withholding | 2023-03-08 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 1,370 | $157.21 | 62,423 (Direct) | View |
| 2023-03-06 Option Award | 2023-03-08 8:00 pm | 2024-03-06 2033-03-06 | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 31,500 | $0 | 62,423 (Direct) | View |
| 2023-03-06 Option Award | 2023-03-08 8:00 pm | 2024-03-06 2033-03-06 | Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director | 4,780 | $0 | 173,250 (Direct) | View |
| 2023-03-06 Tax Withholding | 2023-03-08 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 1,134 | $157.21 | 98,082 (Direct) | View |
| 2023-03-06 Option Award | 2023-03-08 8:00 pm | 2024-03-06 2033-03-06 | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 31,500 | $0 | 98,082 (Direct) | View |
| 2023-03-06 Option Award | 2023-03-08 8:00 pm | 2024-03-06 2033-03-06 | Sarepta Therapeutics Inc. | SRPT | Barry Richard Director | 4,780 | $0 | 3,133,099 (Direct) | View |
| 2023-03-06 Tax Withholding | 2023-03-08 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward SVP, General Counsel | 1,325 | $157.21 | 55,820 (Direct) | View |
| 2023-03-06 Option Award | 2023-03-08 8:00 pm | 2024-03-06 2033-03-06 | Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward SVP, General Counsel | 31,500 | $0 | 55,820 (Direct) | View |
| 2023-03-06 Option Award | 2023-03-08 8:00 pm | 2024-03-06 2033-03-06 | Sarepta Therapeutics Inc. | SRPT | Chambers Michael Andrew Director | 4,780 | $0 | 188,152 (Direct) | View |
| 2023-03-06 Option Award | 2023-03-08 8:00 pm | 2024-03-06 2033-03-06 | Sarepta Therapeutics Inc. | SRPT | Nicaise Claude Director | 4,780 | $0 | 19,585 (Direct) | View |
| 2023-03-06 Option Award | 2023-03-08 8:00 pm | 2024-03-06 2033-03-06 | Sarepta Therapeutics Inc. | SRPT | Boor Kathryn Jean Director | 4,780 | $0 | 9,688 (Direct) | View |
| 2023-03-06 Option Award | 2023-03-08 8:00 pm | 2024-03-06 2033-03-06 | Sarepta Therapeutics Inc. | SRPT | Mayo Stephen Director | 4,780 | $0 | 11,167 (Direct) | View |
| 2023-03-01 Tax Withholding | 2023-03-03 8:01 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer | 252 | $147.57 | 22,828 (Direct) | View |
| 2023-03-01 Tax Withholding | 2023-03-03 8:01 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Brown Ryan Edward SVP, General Counsel | 196 | $147.57 | 25,645 (Direct) | View |
| 2023-03-01 Tax Withholding | 2023-03-03 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Estepan Ian Michael Chief Financial Officer | 378 | $147.57 | 32,293 (Direct) | View |
| 2023-03-01 Tax Withholding | 2023-03-03 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 522 | $147.57 | 67,716 (Direct) | View |
| 2022-12-31 Option Award | 2023-01-04 8:03 pm | 2023-12-31 2032-12-31 | Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer | 30,000 | $0 | 30,000 (Direct) | View |
Ownership | 2023-01-04 8:01 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Arif Bilal Chief Tech Ops Officer | 0 | $0 | 58,567 (Direct) | View |
| 2022-12-19 Exercise | 2022-12-21 09:05 am | N/A N/A | Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director | 20,000 | $34.92 | 168,470 (Direct) | View |
| 2022-12-19 Exercise | 2022-12-21 09:05 am | 2014-06-04 2023-06-04 | Sarepta Therapeutics Inc. | SRPT | BEHRENS M KATHLEEN Director | 20,000 | $0 | 168,470 (Direct) | View |
| 2022-11-17 Tax Withholding | 2022-11-21 8:02 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Rodino-Klapac Louise Head of R&D, CSO | 4,211 | $108.52 | 67,998 (Direct) | View |
| 2022-09-13 Option Award | 2022-09-14 08:00 am | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Chambers Michael Andrew Director | 20,000,000 | $20,000,000 | 20,000,000 (Indirect) | View |
| 2022-06-02 Option Award | 2022-06-06 8:24 pm | 2023-06-02 2032-06-02 | Sarepta Therapeutics Inc. | SRPT | Boor Kathryn Jean Director | 13,237 | $0 | 13,237 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-06 8:22 pm | 2023-06-02 2032-06-02 | Sarepta Therapeutics Inc. | SRPT | Chambers Michael Andrew Director | 13,237 | $0 | 88,431 (Direct) | View |
Ownership | 2022-06-06 8:20 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Chambers Michael Andrew Director | 0 | $0 | 75,194 (Indirect) | View |